Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023

News   Apr 05, 2012

 
Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023
 
 
 

RELATED ARTICLES

Cracking the Code of Coenzyme Q Biosynthesis

News

Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.

READ MORE

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE